MedPath

Effect of the intake of PGX, a novel soluble viscous polysaccharide complex, on Insulin / Cholesterol / Triglycerides and Blood Sugar levels as well as body mass change over 14 weeks in Japanese subjects. A randomised controlled study.

Not Applicable
Conditions
Mildly obese metabolic syndrome subjects
Registration Number
JPRN-UMIN000009196
Lead Sponsor
TTC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Those exercising to slim down, those taking health foods for dieting, or who are taking FOSHU or health foods in relation to body mass (2)Those taking medicines, FOSHU or health foods possibly to affect the levels of serum lipids and blood sugar (3)Those under treatment for hyperlipemia, diabetes or obesity (4)Those who may possibly develop allergic reactions associated with the test products (5)Those having a disease necessitating regular medication or a history of serious diseases for which medication was needed (6)Those participating in another clinical study at the beginning of this study or who are contemplating entering into one during the course of this study (7)Those who are pregnant or breastfeeding during the study period (8)Those who are judged by the principal investigator as inadequate for this study for any other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath